dc.contributor.author | Kaymakoglu, S | |
dc.contributor.author | Tozun, N | |
dc.contributor.author | Hamzaoglu, HO | |
dc.contributor.author | Duman, D | |
dc.contributor.author | Ulker, A | |
dc.contributor.author | Parlak, E | |
dc.contributor.author | Palabiyikoglu, M | |
dc.contributor.author | Dokmeci, A | |
dc.contributor.author | Besisik, F | |
dc.contributor.author | Arslan, S | |
dc.contributor.author | Kav, T | |
dc.contributor.author | Pinarbasi, B | |
dc.date.accessioned | 2021-03-06T08:41:47Z | |
dc.date.available | 2021-03-06T08:41:47Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Arslan S., Kav T., Besisik F., Kaymakoglu S., Pinarbasi B., Tozun N., Hamzaoglu H., Duman D., Ulker A., Parlak E., et al., "Clinical outcome of Crohn's disease treated with infliximab", HEPATO-GASTROENTEROLOGY, cilt.50, ss.952-956, 2003 | |
dc.identifier.issn | 0172-6390 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e22fa65f-4406-4b04-a196-ac96d2d1c3cc | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/148886 | |
dc.description.abstract | Background/Aims: Controlled studies in humans have shown the role of antibodies to tumor necrosis factor-alpha in the treatment of both fistulizing and inflammatory Crohn's disease. The aim of this study is to report the results of a multicenter clinical trial to evaluate efficacy of infliximab in Crohn's disease patients who are refractory to conservative drugs or fistulizing Crohn's disease. | |
dc.language.iso | eng | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | CERRAHİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.title | Clinical outcome of Crohn's disease treated with infliximab | |
dc.type | Makale | |
dc.relation.journal | HEPATO-GASTROENTEROLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 50 | |
dc.identifier.issue | 52 | |
dc.identifier.startpage | 952 | |
dc.identifier.endpage | 956 | |
dc.contributor.firstauthorID | 169006 | |